What’s New — and
Where to Find Us
Conferences we’re attending, plus the latest announcements from the SplashBIO™ team.
Where to Find Us
Upcoming conferences where you can meet the SplashBIO™ team.
CTAD 2026 — Clinical Trials on Alzheimer’s Disease
Join us at CTAD to see how independent, centralized pre-screening reduces screen failures and accelerates enrollment.
Request a meetingNews & Press
Announcements, releases, and coverage.
SplashBIO™ Launches as an Independent Platform Company
SplashBIO™ announced its launch as an independent, biomarker-driven enrollment platform — spun out from Splash Clinical to bring validated blood biomarker pre-screening to the front of the clinical trial, reducing screen failures and accelerating enrollment.
Read the releaseSplashBIO™ Completes Its Scientific Advisory Board
SplashBIO™ announced a four-member Scientific Advisory Board spanning cognition science, biostatistics, bioethics and law, and clinical neurology — bringing deep Alzheimer’s research expertise to its enrollment platform.
Meet the boardBetter Trial Enrollment
Starts Earlier.
Let’s modernize clinical trial enrollment together and unlock a new era of efficiency.